Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
about
AID and APOBECs span the gap between innate and adaptive immunityNatural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivitydUTPase: the frequently overlooked enzyme encoded by many retrovirusesImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoThe Road Less Traveled: HIV's Use of Alternative Routes through Cellular PathwaysStructural Insights into HIV-1 Vif-APOBEC3F InteractionMechanisms of viral mutationWhere in the Cell Are You? Probing HIV-1 Host Interactions through Advanced Imaging TechniquesInteraction of APOBEC3A with DNA assessed by atomic force microscopyExtremely High Mutation Rate of HIV-1 In VivoA naturally occurring bovine APOBEC3 confers resistance to bovine lentiviruses: implication for the co-evolution of bovids and their lentivirusesThe Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from MonkeysCyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryDifferent modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.Retroviral vectors for analysis of viral mutagenesis and recombination.APOBEC3F determinants of HIV-1 Vif sensitivityPromiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Vif determines the requirement for CBF-β in APOBEC3 degradationStructure of the Vif-binding domain of the antiviral enzyme APOBEC3GCharacterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesisAPOBEC3G Interacts with ssDNA by Two Modes: AFM Studies.Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis.Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cellsCrystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral LoadNatural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression LevelsA computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.APOBEC3 proteins can copackage and comutate HIV-1 genomes.
P2860
Q21131084-70ED9BBE-0F42-48CC-BB8D-E8DF6F46B8CEQ21144862-A19D5145-BA58-4B6E-A62F-E7B2B870372EQ26799724-48B5B215-6FBF-4219-B1F0-70361FD233F6Q26851152-5389E770-4F77-4131-900F-B063F82196FEQ27027607-15FC5D08-CB82-4F19-9050-C9B52C6D4495Q27321018-BFEBF645-60E3-47A3-9F4F-4C90806306E6Q28067235-B28AB55F-ABDE-42CC-9EC5-E05D8D7BA91FQ28077744-8AE2C691-C78D-43C4-8B6E-279F23CB8CA5Q28539478-79261B75-4043-4B03-868B-82898E02CF32Q28548089-64360314-AF4F-4A37-8AF6-92FC559F2E29Q28598363-86A5863D-F338-4E56-9EC3-0C0C067A1268Q30379417-FDE13AA7-8E27-427E-8DB0-A401820183CCQ33567848-34B7AFF5-9DB5-4085-A3B9-F7E9F857A065Q33650603-62AFD1AA-0488-4CBA-AB0C-1CA150D58AACQ33690901-1D6CF668-1097-4D43-A788-A75C7412338CQ33982561-1481ED76-67B3-4229-A432-37C3D340411EQ34261416-97E60026-F617-44F7-9B29-A185C2BCF1D3Q34303615-3A3E56FD-BD40-4CBC-9F18-5BFC93031153Q34593923-07A36A10-D34F-4F60-BD06-F2CC1A1DEF17Q34972927-855317C1-9140-4A91-82BF-59F5A320A05CQ35068754-5FFCA45B-B419-4B14-97C8-54D3ED3D625FQ35182748-9B42EEE1-2386-456F-A70D-515BAB24E747Q35685282-19D05DE3-F2F5-4ABC-938F-6C0100A2AF3EQ35747955-3F86415B-5227-40BA-AF79-F5BCB43B1DB3Q35834559-3EFF9144-7B66-4DB5-8008-EE178B66A4BDQ35836909-F88C91AB-9927-4AC4-B4F8-938CEABF9EBCQ36158234-DD6ED0ED-112A-4A2E-AC63-78246DCF9DE6Q36209528-FD344B18-CC06-4E05-B355-96465B859762Q36276957-A9DC5820-A6D6-4468-B1A2-BBC87189FA8FQ36283884-D509E737-E02F-4E59-895A-B1D406093C99Q36287580-4FAFAF04-3A7E-4B34-84E0-DFBA378A5D02Q36301232-F3E486AE-BCE4-484B-9B3B-833FA3134806Q36348886-E24650C0-4951-46B6-988E-43A02F079451Q36371387-D6E830C4-237A-41A7-99D5-DF2A252FBB6CQ36384317-ADC33157-D960-40C6-8C15-0B4BA35B41A0Q36608205-7DF63E47-1234-4E8F-9905-FBE60D7FCE97Q36811895-B38092F5-6189-46DF-BFE1-11AE41821EFFQ36871140-211BD7BC-7F24-4869-AD6A-56FE4A0CBB5AQ37091342-6F178CD7-D229-491A-B7C1-05CC2B3AEA1BQ37264399-BDAEDB5E-E8C4-40FD-95C8-9350FD368F96
P2860
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@ast
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@en
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@nl
type
label
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@ast
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@en
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@nl
prefLabel
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@ast
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@en
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@nl
P2860
P50
P3181
P1476
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all
@en
P2093
Krista A Delviks-Frankenberrry
Ryan C Burdick
P2860
P304
P3181
P356
10.1016/J.JMB.2013.10.033
P407
P577
2014-03-20T00:00:00Z